Actos (Pioglitazone)
€87.00 – €212.00
Description
Actos (Pioglitazone) – Product Description
Actos (pioglitazone) is an oral antidiabetic medication belonging to the thiazolidinedione (TZD) class. It is used to improve blood sugar control in adults with type 2 diabetes mellitus, primarily by enhancing insulin sensitivity in fat, muscle, and liver cells. Unlike insulin or sulfonylureas, it does not cause hypoglycemia when used alone.Big Actos (Pioglitazone) online
Key Features & Benefits
✔ Insulin Sensitizer – Reduces insulin resistance, helping the body use its own insulin more effectively.Big Actos (Pioglitazone) online
✔ Long-Term Glucose Control – Lowers HbA1c by 1–1.5% on average.
✔ Cardiovascular Safety – Unlike some older diabetes drugs, it does not increase heart attack risk (may even have mild protective effects).
✔ Monotherapy or Combination Use – Can be taken alone or with metformin, sulfonylureas, or insulin.
Dosage & Administration
Available Strengths: 15mg, 30mg, 45mg tablets.
Typical Starting Dose: 15–30mg once daily (with or without food).
Max Dose: 45mg/day (higher doses show diminishing returns).
Adjustment Needed in Liver Disease – Monitor liver enzymes.
Mechanism of Action
PPAR-γ Agonist – Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), a nuclear receptor that regulates genes involved in glucose and lipid metabolism.
Effects:
Increases adiponectin (improves insulin sensitivity).
Reduces hepatic glucose production.
Enhances fatty acid storage in adipose tissue (can lead to weight gain).
Potential Side Effects
⚠ Common:
Weight gain (2–4 kg average, due to fluid retention + fat redistribution).
Edema (swelling in legs/ankles).
Increased LDL cholesterol (but may improve HDL).
⚠ Serious (Rare):Bladder cancer risk (controversial; higher with long-term/high-dose use).
Heart failure (avoid in NYHA Class III/IV patients).
Bone fractures (higher risk in postmenopausal women).
Contraindications & Warnings
Heart failure (can worsen fluid retention).
Active bladder cancer (or history of it).
Liver disease (monitor ALT before/during treatment).
Pregnancy (Category C) – Not recommended.
Comparison to Other Diabetes Drugs
Feature | Actos (Pioglitazone) | Metformin | SGLT2 Inhibitors (e.g., Jardiance) |
---|---|---|---|
Mechanism | PPAR-γ agonist | AMPK activator | Blocks kidney glucose reabsorption |
Hypoglycemia Risk | Low (unless combined with insulin/SUs) | Very low | Low |
Weight Effect | Gain (2–4 kg) | Neutral/Loss | Moderate loss |
Cardiovascular Impact | Neutral/mild benefit | Protective | Proven CV benefit |
Storage & Handling
Room temperature (avoid moisture).
No refrigeration needed.
Final Notes
Actos is best suited for type 2 diabetics with insulin resistance but requires monitoring for fluid retention, weight gain, and liver function. Due to its slow onset (takes weeks for full effect), it is not for acute blood sugar control.
Disclaimer: Actos is a prescription drug. Use under medical supervision only.
Additional information
Dosage | 7.5mg, 15mg, 30mg, 45mg |
---|---|
Quantity | 60 Tabs, 90 Tabs |
Reviews
There are no reviews yet.